Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India · Delayed Price · Currency is INR 1,310.00
-8.50 (-0.64%)
May 22, 2026, 3:29 PM IST
Dr. Reddy's Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 42,850 | 56,544 | 55,684 | 45,067 | 23,568 |
Depreciation & Amortization | 20,605 | 17,058 | 14,841 | 12,636 | 11,824 |
Loss (Gain) From Sale of Assets | -2,547 | -1,522 | -900 | 208 | -1,119 |
Asset Writedown & Restructuring Costs | 3,519 | 1,693 | 3 | 699 | 7,562 |
Loss (Gain) From Sale of Investments | -2,359 | -3,554 | -3,149 | -876 | -277 |
Loss (Gain) on Equity Investments | -134 | -217 | -147 | -370 | -703 |
Stock-Based Compensation | 326 | 424 | 407 | 397 | 592 |
Provision & Write-off of Bad Debts | 690 | 161 | 275 | 205 | 55 |
Other Operating Activities | 5,441 | 5,830 | -1,399 | 8,764 | 5,104 |
Change in Accounts Receivable | -6,722 | -10,283 | -8,054 | -5,752 | -17,012 |
Change in Inventory | -8,601 | -12,753 | -18,445 | -2,654 | -9,912 |
Change in Accounts Payable | 2,790 | 340 | 3,460 | 23 | 4,412 |
Change in Other Net Operating Assets | 897 | -7,293 | 2,857 | 528 | 4,014 |
Operating Cash Flow | 56,755 | 46,428 | 45,433 | 58,875 | 28,108 |
Operating Cash Flow Growth | 22.24% | 2.19% | -22.83% | 109.46% | -21.27% |
Capital Expenditures | -23,326 | -27,504 | -16,403 | -11,323 | -14,660 |
Sale of Property, Plant & Equipment | 309 | 512 | 1,064 | 82 | 370 |
Cash Acquisitions | -3,152 | -53,096 | - | - | -326 |
Sale (Purchase) of Intangibles | -13,698 | -6,162 | -11,011 | -7,543 | -1,443 |
Investment in Securities | -27,167 | 24,801 | -15,716 | -23,366 | -11,201 |
Other Investing Activities | 1,521 | 3,372 | 1,783 | 777 | 873 |
Investing Cash Flow | -65,513 | -58,077 | -40,283 | -41,373 | -26,387 |
Short-Term Debt Issued | 20,257 | 24,490 | 5,493 | - | 3,520 |
Long-Term Debt Issued | - | - | 3,800 | - | - |
Total Debt Issued | 20,257 | 24,490 | 9,293 | - | 3,520 |
Short-Term Debt Repaid | - | - | - | -19,382 | - |
Long-Term Debt Repaid | -1,264 | -1,294 | -4,947 | -1,015 | -785 |
Total Debt Repaid | -1,264 | -1,294 | -4,947 | -20,397 | -785 |
Net Debt Issued (Repaid) | 18,993 | 23,196 | 4,346 | -20,397 | 2,735 |
Issuance of Common Stock | 397 | 193 | 805 | 368 | 334 |
Repurchase of Common Stock | - | -1,389 | - | - | - |
Common Dividends Paid | -6,659 | -6,662 | -6,648 | -4,979 | -4,146 |
Other Financing Activities | -4,441 | 3,573 | -2,266 | -1,853 | -1,345 |
Financing Cash Flow | 8,290 | 18,911 | -3,763 | -26,861 | -2,422 |
Foreign Exchange Rate Adjustments | 1,243 | 224 | -59 | 286 | 733 |
Net Cash Flow | 775 | 7,486 | 1,328 | -9,073 | 32 |
Free Cash Flow | 33,429 | 18,924 | 29,030 | 47,552 | 13,448 |
Free Cash Flow Growth | 76.65% | -34.81% | -38.95% | 253.60% | -48.20% |
Free Cash Flow Margin | 9.95% | 5.81% | 10.40% | 19.34% | 6.27% |
Free Cash Flow Per Share | 40.12 | 22.69 | 34.83 | 57.16 | 16.17 |
Cash Interest Paid | 4,441 | 3,483 | 2,266 | 1,853 | 1,345 |
Cash Income Tax Paid | 13,526 | 19,993 | 20,047 | 10,714 | 7,437 |
Levered Free Cash Flow | 1,741 | 11,920 | 12,406 | 29,677 | 1,031 |
Unlevered Free Cash Flow | 4,077 | 13,688 | 13,476 | 30,569 | 1,629 |
Change in Working Capital | -11,636 | -29,989 | -20,182 | -7,855 | -18,498 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.